参考文献/References:
[1] Jellinger KA,Wenning GK.Multiple system atrophy: pathogenic mechanisms and biomarkers[J].J Neural Transm,2016,123(6):555-572.
[2] Tomasz B,Kristian W,Tina KA,et al.Screening of Toll-Like receptors expression in multiple system atrophy brains[J].Neurochem Res,2013,38(6):1252-1259.
[3] Fellner L,Irschick R,Schanda K,et al.Toll-like receptor 4 is required for α-synuclein dependent activation of microglia and astroglia[J].Glia,2013,61(3):349-360.
[4] Ishizawa K,Komori T,Sasaki S,et al.Microglial activation parallels system degeneration in multiple system atrophy[J].J Neuropathol Exp Neurol,2004,63(1):43-52.
[5] Kübler D,Tobias W,Cabanel N,et al.Widespread microglial activation in multiple system atrophy[J].Movement Disorders,2019,34(4):564-568.
[6] Nakamura K,Mori F,Kon T,et al.Accumulation of phosphorylated α-synuclein in subpial and periventricular astrocytes in multiple system atrophy of long duration[J].Neuropathology,2016,36(2):157-167.
[7] Xian P,Yue H,Rui W,et al.Mesenchymal stem cell-derived exosomes as a nanotherapeutic agent for amelioration of inflammation-induced astrocyte alterations in mice[J].Theranostics,2019,9(20):5956-5975.
[8] Wilson EH,Weninger W,Christopher AH.Trafficking of immune cells in the central nervous system[J].Journal of Clinical Investigation,2010,120(5):1368-1379.
[9] Csencsits-Smith K,Jessika S,Kan L,et al.Serum Lymphocyte-Associated cytokine concentrations change more rapidly over time in multiple system atrophy compared to parkinson disease[J].Neuroimmunomodulation,2016,23(5/6):301-308.
[10] Reynolds AD,David KS,Mosley RL,et al.Nitrated α-Synuclein-Induced alterations in microglial immunity are regulated by CD4+ T cell subsets[J].J Immunol,2009,182(7):4137-4149.
[11] Lee HJ,Kim C,Seung-Jae L.Alpha-Synuclein stimulation of astrocytes: potential role for neuroinflammation and neuroprotection[J].Oxid Med Cell Longev,2010,3(4):283-287.
[12] Fares B,Arnaud M,Marie-Helene C,et al.Region-Specific alterations of matrix metalloproteinase activity in multiple system atrophy[J].Movement Disorders,2015,30(13):1802-1812.
[13] Li FZ,Takashi A,Maki T,et al.NLRP3 Inflammasome-Related proteins are upregulated in the putamen of patients with multiple system atrophy[J].J Neuropathol Exp Neurol,2018,77(11):1055-1065.
[14] Aoife PK,Christina EM,Sandrine CF,et al.Immunohistochemical and molecular investigations show alteration in the inflammatory profile of multiple system atrophy brain[J].J Neuropathol Exp Neurol,2018,77(7):598-607.
[15] Yamasaki R,Yamaguchi H,Matsushita T,et al.Early strong intrathecal inflammation in cerebellar type multiple system atrophy by cerebrospinal fluid cytokine/chemokine profiles: a case control study[J].J Neuroinflammation,2017,14(1):89.
[16] Zhang LJ,Ma PJ,Guan QK,et al.Effect of chemokine CC ligand 2(CCL2)on a synuclein induced microglia proliferation and neuronal apoptosis[J].Mol Med Rep,2018,18(5):4213-4218.
[17] Stefanova N,Reindl M,Neumann M,et al.Oxidative stress in transgenic mice with oligodendroglial α-Synuclein overexpression replicates the characteristic neuropathology of multiple system atrophy[J].Am J Pathol,2005,166(3):869-876.
[18] Emanuele B,Kleiner G,Tang GM,et al.Decreased coenzyme Q10 levels in multiple system atrophy cerebellum[J].J Neuropathol Exp Neurol,2016,75(7):663-672.
[19] Béraud D,Hathaway HA,Trecki J,et al.Microglial activation and antioxidant responses induced by the parkinson's disease protein α-Synuclein[J].Journal of Neuroimmune Pharmacology,2013,8(1):94-117.
[20] Sook KS,Seung-Koo L,Jae JL,et al.Blood-brain barrier impairment is functionally correlated with clinical severity in patients of multiple system atrophy[J].Neurobiol Aging,2011,32(12):2183-2189.
[21] Shinya D,Takata F,Matsumoto J,et al.Monomeric α-synuclein induces blood-brain barrier dysfunction through activated brain pericytes releasing inflammatory mediators in vitro[J].Microvasc Res,2019,124:61-66.
[22] Bartels AL,Willemsen AM,Kortekaas R,et al.Decreased blood-brain barrier P-glycoprotein function in the progression of Parkinson's disease, PSP and MSA[J].J Neural Transm,2008,115(7):1001-1009.
[23] Mandler M,Valera E,Rockenstein E,et al.Active immunization against alpha-synuclein ameliorates the degenerative pathology and prevents demyelination in a model of multiple system atrophy[J].Mol Neurodegener,2015,10(10).DOI:10.1/86/S13024-015-0008-9.
[24] Shiraishi W,Iwanaga Y,Yamamoto A.A case of an anti-Ma2 antibody-positive patient presenting with variable CNS symptoms mimicking multiple system atrophy with a partial response to immunotherapy[J].Rinsho Shinkeigaku Clinical Neurology,2015,55(2):96-100.